Selskabets formål er handel - herunder eksport, import - produktion samt anden i forbindelse hermed stående virksomhed, bl.a. restaurationsvirksomhed
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 518 mio. | 26.7 mio. | 473.5 mio. | 181.4 mio. | 473 | |
CVR: 67303016
Secondary names: AIR NORTH ApS, DANHEKO ApS, FITNESS PARTNER ApS
4 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 168 companies in Fremstilling af andre fødevarer i.a.n.
Comparison is based on industry median values
Companies in the same industry and area
PHARMA NORD ApS demonstrates a stable financial health with a consistent revenue growth trajectory, increasing from 439.4 million DKK in 2022 to 518 million DKK in 2025. However, profit has shown volatility, peaking at 57.97 million DKK in 2021 before declining to 26.71 million DKK in 2025. The company's equity has fluctuated, ending at 181.4 million DKK in 2025, indicating a solid capital base but with some concerns regarding profit margins. Overall, PHARMA NORD maintains a significant position within the food manufacturing industry, although attention to profitability trends and equity management will be crucial for sustained growth.
AI-generated summary
companydata.dk